Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)
Tsuyoshi Otsuji,1 Yoshimi Nagai,2 Kenichiro Sho,1 Akiko Tsumura,1 Naoko Koike,1 Mei Tsuda,1 Tetsuya Nishimura,1 Kanji Takahashi2 1Department of Ophthalmology, Kansai Medical University, Takii Hospital, Osaka, Japan; 2Department of Ophthalmology, Kansai Medical University, Hirakata Hospital, Osaka, J...
Enregistré dans:
Auteurs principaux: | Otsuji T, Nagai Y, Sho K, Tsumura A, Koike N, Tsuda M, Nishimura T, Takahashi K |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/39faaa2deaa44e92a4d7a740e4fe989e |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration
par: Koike N, et autres
Publié: (2019) -
Three-year results of a modified photodynamic therapy procedure (Ironing PDT) for age-related macular degeneration patients with large lesions
par: Otsuji T, et autres
Publié: (2016) -
Initial clinical experience of ranibizumab therapy for neovascular age-related macular degeneration
par: Tryfon Rotsos, et autres
Publié: (2010) -
Comparison of the effect between pegaptanib and ranibizumab on exudative age-related macular degeneration with small lesion size
par: Fujihara M, et autres
Publié: (2012) -
Treatment of age-related macular degeneration: focus on ranibizumab
par: Martin S Spitzer, et autres
Publié: (2008)